New details from the indictment against a fertility clinic in Crete allege that a single egg donor was used for 63 recipients, and that families paid up to €120,000 for a baby. The charges follow what prosecutors describe as a large-scale fraud operation at the clinic. The trial, which began this month, is now moving forward with these specifics on the record.
If you are pursuing egg donation internationally, the donor limitation policies of your clinic are worth asking about directly. One donor for dozens of recipients is far outside accepted practice.
Attorneys for the Arcadia couple at the center of the 21-child surrogacy case are now seeking their clients' release from jail. Separately, reporting describes a years-long trail of alleged red flags connected to the couple. The bail was previously set at $20 million each.
This case continues to move through the courts. Nothing here changes what families using legitimate U.S. surrogacy agencies need to do, but it is a reminder that vetting any arrangement carefully matters.
A judge from the African Court has stated publicly that Ghana needs a comprehensive surrogacy law to address what he describes as complex legal disputes arising in the absence of clear legislation. The call comes as Ghana's highest court recently flagged citizenship and inheritance risks for children born through surrogacy. No legislation has been introduced yet.
Worth watching, especially for anyone with ties to Ghana or other West African nations where surrogacy law remains unsettled.
The Telegraph published an opinion piece arguing that a culture of uncritical positivity around surrogacy prevents honest conversation about exploitation and harm within the industry. The piece challenges the framing that criticism of commercial surrogacy is inherently unkind to the families involved. It does not focus on a specific case but addresses the industry broadly.
This one is worth reading critically. Skeptical coverage of surrogacy often blurs the line between genuine reform arguments and opposition to the practice altogether. Knowing what critics are saying helps families ask better questions of their agencies and attorneys.
A new study reported by Bioengineer.org found that a simplified fertility drug dosing approach produces outcomes comparable to the standard protocol in IVF freeze-all cycles. The research suggests that patients may not need the more complex regimen currently used in many clinics. The findings could have implications for cost and convenience for IVF patients.
If you are currently in an IVF protocol or planning one, this is a conversation to bring to your reproductive endocrinologist. It does not mean your clinic's approach is wrong, but it is the kind of study worth raising.
The most striking thread today is the gap between industry self-presentation and institutional scrutiny. On the same day a press release celebrates surrogate-centered care, a judge in Africa calls for new law to fill a legal vacuum, a Greek clinic stands indicted for using one donor for 63 recipients, and a major British newspaper argues that warmth and good intentions have become a shield against accountability. That tension, between genuine compassion in the industry and the structural conditions that allow abuse, is the real story underneath the headlines.
Know ThisASRM Surrogate Guidelines: What They Require
The American Society for Reproductive Medicine, known as ASRM, publishes guidelines that fertility clinics across the country use to evaluate whether someone is a good candidate to carry a pregnancy for another family. These guidelines are not laws, but they represent the gold standard of medical and ethical practice, and most reputable clinics follow them closely to protect everyone involved.
One of the most consistent requirements is that a prospective surrogate must have already carried and delivered at least one healthy pregnancy of her own. This prior experience demonstrates that her body can support a full-term pregnancy and that she understands, emotionally and physically, what the journey involves. ASRM also recommends that surrogates fall within an age range of roughly 21 to 45, though individual clinics may adjust this slightly based on their own medical assessments.
Body mass index, or BMI, is evaluated because it directly affects both the success of an embryo transfer and the safety of the pregnancy itself. Most clinics look for a BMI under 33, though this threshold can vary. A thorough medical screening follows, reviewing uterine health, infectious disease status, and overall physical readiness to carry a pregnancy.
Psychological evaluation is considered just as essential as the medical review. A licensed mental health professional meets with the prospective surrogate — and often her partner — to make sure she has realistic expectations, a strong support system, and a clear understanding of the emotional complexities of carrying a child for someone else.
Finally, ASRM strongly recommends that every surrogate work with her own independent legal counsel, completely separate from the attorneys representing the intended parents. This step exists to make sure her rights are fully protected and that she enters any legal agreement with complete understanding and without outside pressure.
Get this brief in your inbox every morning.
One email, the stories that matter for your journey, explained.